Late sodium current: A mechanism for angina, heart failure, and arrhythmia

Trends in Cardiovascular Medicine

Volumn 26, Issue 2, 2016, Pages 115-122

  Makielski, Jonathan C ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Antiarrhythmic drugs; Long QT syndrome; Sodium current

Indexed keywords

4 [3 (4 BENZHYDRYL 1 PIPERAZINYL) 2 HYDROXYPROPOXY] 1H INDOLE 2 CARBONITRILE; CALCIUM; SODIUM CHANNEL; SODIUM ION; CARDIOVASCULAR AGENT;

ACTION POTENTIAL; ANGINA PECTORIS; ELECTROPHYSIOLOGY; GENETIC DISORDER; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HEART MUSCLE; HOMEOSTASIS; HUMAN; LONG QT SYNDROME; LONG QT SYNDROME 10; LONG QT SYNDROME 12; LONG QT SYNDROME 3; LONG QT SYNDROME 9; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; SODIUM CELL LEVEL; SODIUM CURRENT; TECHNOLOGY; ARRHYTHMIAS, CARDIAC; HEART FUNCTION TEST; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ACTION POTENTIALS; ANGINA PECTORIS; ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR AGENTS; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HEART FAILURE; HUMANS; SODIUM CHANNELS;

EID: 84959160481     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2015.05.006     Document Type: Review

References (50)

1. + current in human ventricle: implications for sodium loading and homeostasis. J Cardiovasc Electrophysiol 2006, 17(Suppl. 1):S15-S20.
2. Gupta T., Khera S., Kolte D., Aronow W.S., Iwai S. Antiarrhythmic properties of ranolazine: a review of the current evidence. Int J Cardiol 2015, 187:66-74.
3. Sossalla S., Maier L.S. Role of ranolazine in angina, heart failure, arrhythmias, and diabetes. Pharmacol Ther 2012, 133:311-323.
4. Noble D., Noble P.J. Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload. Heart 2006, 92(Suppl. 4):iv1-iv5.
5. Maltsev V.A., Undrovinas A. Late sodium current in failing heart: friend or foe?. Prog Biophys Mol Biol 2008, 96:421-451.
6. Antzelevitch C., Nesterenko V., Shryock J.C., Rajamani S., Song Y., Belardinelli L. The role of late I Na in development of cardiac arrhythmias. Handb Exp Pharmacol 2014, 221:137-168.
7. + current: proarrhythmic effects, roles in long QT syndromes, and pathological relationship to CaMKII and oxidative stress. Heart Rhythm 2015, 12:440-448.
8. Na in the cardiomyocyte. Cardiovasc Res 2013, 99:600-611.
9. Dudel J., Peper K., Rudel R., Trautwein W. Effect of tetrodotoxin on membrane currents in mammalian cardiac fibres. Nature 1967, 213:296-297.
10. Attwell D., Cohen I., Eisner D., Ohba M., Ojeda C. The steady state TTX-sensitive ("window") sodium current in cardiac Purkinje fibres. Pflugers Arch 1979, 379:137-142.
11. Colatsky T.J. Mechanisms of action of lidocaine and quinidine on action potential duration in rabbit cardiac Purkinje fibers. An effect on steady state sodium currents?. Circ Res 1982, 50:17-27.
12. Gintant G.A., Datyner N.B., Cohen I.S. Slow inactivation of a tetrodotoxin-sensitive current in canine cardiac Purkinje fibers. Biophys J 1984, 45:509-512.
13. Carmeliet E. Slow inactivation of the sodium current in rabbit cardiac Purkinje fibres. Pflugers Arch 1987, 408:18-26.
14. Wasserstrom J.A., Salata J.J. Basis for tetrodotoxin and lidocaine effects on action potentials in dog ventricular myocytes. Am J Physiol 1988, 254:H1157-H1166.
15. Liu Y.M., DeFelice L.J., Mazzanti M. Na channels that remain open throughout the cardiac action potential plateau. Biophys J 1992, 63:654-662.
16. Saint D.A., Ju Y.K., Gage P.W. A persistent sodium current in rat ventricular myocytes. J Physiol 1992, 453:219-231.
17. Ono K., Fozzard H.A., Hanck D.A. A direct effect of forskolin on sodium channel bursting. Pflugers Arch 1995, 429:561-569.
18. Na-L determines interregional differences in rate adaptation of repolarization. Heart Rhythm 2015, 12:1295-1303.
19. Kyle J.W., Makielski J.C. Diseases caused by mutations in NaV1.5 interacting proteins. Card Electrophysiol Clin 2015, 6:797-809.
20. Mishra S., Reznikov V., Maltsev V.A., Undrovinas N.A., Sabbah H.N., Undrovinas A. Contribution of sodium channel neuronal isoform NaV1.1 to late sodium current in ventricular myocytes from failing hearts. J.Physiol 2015, 593:1409-1427.
21. Yang T., Atack T.C., Stroud D.M., Zhang W., Hall L., Roden D.M. Blocking Scn10a channels in heart reduces late sodium current and is antiarrhythmic. Circ Res 2012, 111:322-332.
22. Ueda K., Valdivia C., Medeiros-Domingo A., Tester D.J., Vatta M., Farrugia G., et al. Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex. Proc Natl Acad Sci U S A 2008, 105:9355-9360.
23. Cheng J., Valdivia C.R., Vaidyanathan R., Balijepalli R.C., Ackerman M.J., Makielski J.C. Caveolin-3 suppresses late sodium current by inhibiting nNOS-dependent S-nitrosylation of SCN5A. J Mol Cell Cardiol 2013, 61:102-110.
24. 2+/calmodulin-dependent protein kinase II (CaMKII) regulates cardiac sodium channel NaV1.5 gating by multiple phosphorylation sites. J Biol Chem 2012, 287:19856-19869.
25. Valdivia C.R., Nagatomo T., Makielski J.C. Late Na currents affected by alpha subunit isoform and β1 subunit co-expression in HEK293 cells. J Mol Cell Cardiol 2002, 34:1029-1039.
26. + channel isoform NaV1.5 is modulated by its β1 subunit. J Physiol Sci 2009, 59:217-225.
27. Medeiros-Domingo A., Kaku T., Tester D.J., Iturralde-Torres P., Itty A., Ye B., et al. SCN4B-encoded sodium channel β4 subunit in congenital long-QT syndrome. Circulation 2007, 116:136-142.
28. Ou Y.J., Strege P., Miller S.M., Makielski J., Ackerman M., Gibbons S.J., et al. Syntrophin γ2 regulates SCN5A Gating by a PDZ domain-mediated interaction. J Biol Chem 2003, 278:1915-1923.
29. Williams J.C., Armesilla A.L., Mohamed T.M., Hagarty C.L., McIntyre F.H., Schomburg S., et al. The sarcolemmal calcium pump, α-1 syntrophin, and neuronal nitric-oxide synthase are parts of a macromolecular protein complex. J Biol Chem 2006, 281:23341-23348.
30. Ahern G.P., Hsu S.F., Klyachko V.A., Jackson M.B. Induction of persistent sodium current by exogenous and endogenous nitric oxide. J Biol Chem 2000, 275:28810-28815.
31. 2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc Res 2007, 73:631-640.
32. Tan H.L., Kupershmidt S., Zhang R., Stepanovic S., Roden D.M., Wilde A.A., et al. A calcium sensor in the sodium channel modulates cardiac excitability. Nature 2002, 415:442-447.
33. Potet F., Chagot B., Anghelescu M., Viswanathan P.C., Stepanovic S.Z., Kupershmidt S., et al. Functional interactions between distinct sodium channel cytoplasmic domains through the action of calmodulin. J Biol Chem 2009, 284:8846-8854.
34. + channels. J Clin Invest 2006, 116:3127-3138.
35. + channel inactivation gate is required for modulation by protein kinase C. J Gen Physiol 1996, 108:375-379.
36. NCX induced by ouabain-increased late sodium current in rabbit ventricular myocytes. Exp Physiol 2015, 100:399-409.
37. Ballou L.M., Lin R.Z., Cohen I.S. Control of cardiac repolarization by phosphoinositide 3-kinase signaling to ion channels. Circ Res 2015, 116:127-137.
38. Lu Z., Wu C.Y., Jiang Y.P., Ballou L.M., Clausen C., Cohen I.S., et al. Suppression of phosphoinositide 3-kinase signaling and alteration of multiple ion currents in drug-induced long QT syndrome. Sci Transl Med 2012, 4:131ra50.
39. Kr block is insufficient to detect torsades de pointes liability: role of late sodium current. Circulation 2014, 130:224-234.
40. + channel activators as positive inotropic agents for the treatment of chronic heart failure. Cardiovasc Drugs Ther 2001, 15:379-386.
41. Nagatomo T., Ye B., Valdivia C.R., Fan Z., January C.T., Makielski J.C. Frequency-dependent reduction of late Na current by ultra-slow recovery in the LQT3 D KPQ mutant Na channel. Circulation 1998, 98:469.
42. + channel. Circulation 1999, 99:3165-3171.
43. Ackerman M.J., Siu B.L., Sturner W.Q., Tester D.J., Valdivia C.R., Makielski J.C., et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. J Am Med Assoc 2001, 286:2264-2269.
44. + channel in cardiac disease. Circulation 2012, 126:2084-2094.
45. Zaza A., Belardinelli L., Shryock J.C. Pathophysiology and pharmacology of the cardiac "late sodium current". Pharmacol Ther 2008, 119:326-339.
46. Bers D.M. Excitation-contraction coupling and cardiac contractile force 2001, Kluwer Academic Press. 2nd ed.
47. Fernandes S., Hoyer K., Liu G., Wang W.Q., Dhalla A.K., Belardinelli L., et al. Selective inhibition of the late sodium current has no adverse effect on electrophysiological or contractile function of the normal heart. J Cardiovasc Pharmacol 2014, 63:512-519.
48. Fredj S., Sampson K.J., Liu H., Kass R.S. Molecular basis of Ranolazine block of LQT-3 mutant sodium channels: evidence for site of action. Br J Pharmacol 2006, 148:16-24.
49. Mishra S., Undrovinas N.A., Maltsev V.A., Reznikov V., Sabbah H.N., Undrovinas A. Post-transcriptional silencing of SCN1B and SCN2B genes modulates late sodium current in cardiac myocytes from normal dogs and dogs with chronic heart failure. Am J Physiol Heart Circ Physiol 2011, 301:H1596-H1605.
50. Campbell T.J., Williams K.M. Therapeutic drug monitoring: antiarrhythmic drugs. Br J Clin Pharmacol 2001, 52(Suppl. 1):21S-34S.